-
Publication Venue For
-
Diminished Structural Brain Integrity in Long-term Cannabis Users Reflects a History of Polysubstance Use..
92:861-870.
2022
-
Long-term Neural Embedding of Childhood Adversity in a Population-Representative Birth Cohort Followed for 5 Decades..
90:182-193.
2021
-
Convergent Evidence for Predispositional Effects of Brain Gray Matter Volume on Alcohol Consumption..
87:645-655.
2020
-
Epigenome-wide Association Study of Attention-Deficit/Hyperactivity Disorder Symptoms in Adults..
86:599-607.
2019
-
Replication in Imaging Genetics: The Case of Threat-Related Amygdala Reactivity..
84:148-159.
2018
-
A Connectome Wide Functional Signature of Transdiagnostic Risk for Mental Illness
2018
-
Amygdala Reward Reactivity Mediates the Association Between Preschool Stress Response and Depression Severity..
83:128-136.
2018
-
Imaging Genetics and Genomics in Psychiatry: A Critical Review of Progress and Potential..
82:165-175.
2017
-
A Common Polymorphism in a Williams Syndrome Gene Predicts Amygdala Reactivity and Extraversion in Healthy Adults..
81:203-210.
2017
-
Interactions Between Anandamide and Corticotropin-Releasing Factor Signaling Modulate Human Amygdala Function and Risk for Anxiety Disorders: An Imaging Genetics Strategy for Modeling Molecular Interactions..
80:356-362.
2016
-
Blunted Ventral Striatum Development in Adolescence Reflects Emotional Neglect and Predicts Depressive Symptoms..
78:598-605.
2015
-
Testosterone rapidly increases neural reactivity to threat in healthy men: a novel two-step pharmacological challenge paradigm..
76:324-331.
2014
-
An inflammatory pathway links atherosclerotic cardiovascular disease risk to neural activity evoked by the cognitive regulation of emotion..
75:738-745.
2014
-
Testosterone Rapidly Increases Neural Reactivity to Threat in Healthy Men: A Novel Two-Step Pharmacological Challenge Paradigm
2014
-
A thalamocorticostriatal dopamine network for psychostimulant-enhanced human cognitive flexibility..
74:99-105.
2013
-
Can food and addiction change the game?.
73:802-803.
2013
-
An Inflammatory Pathway Links Atherosclerotic Cardiovascular Disease Risk to Neural Activity Evoked by the Cognitive Regulation of Emotion
2013
-
Functional brain activation to emotionally valenced faces in school-aged children with a history of preschool-onset major depression..
72:1035-1042.
2012
-
Ventral striatum reactivity to reward and recent life stress interact to predict positive affect..
72:157-163.
2012
-
Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial..
71:939-946.
2012
-
Adenylate cyclase 7 is implicated in the biology of depression and modulation of affective neural circuitry..
71:627-632.
2012
-
Blunted cortisol responses to stress signal social and behavioral problems among maltreated/bullied 12-year-old children..
70:1016-1023.
2011
-
The what, where, and when of catechol-O-methyltransferase..
70:214-215.
2011
-
Structural magnetic resonance imaging in bipolar disorder: an international collaborative mega-analysis of individual adult patient data..
69:326-335.
2011
-
Arguable assumptions, debatable conclusions..
67:e19-e20.
2010
-
Preferential amygdala reactivity to the negative assessment of neutral faces..
66:847-853.
2009
-
Genetic vulnerability to affective psychopathology in childhood: a combined voxel-based morphometry and functional magnetic resonance imaging study..
66:231-237.
2009
-
Divergent effects of genetic variation in endocannabinoid signaling on human threat- and reward-related brain function..
66:9-16.
2009
-
Preclinical atherosclerosis covaries with individual differences in reactivity and functional connectivity of the amygdala..
65:943-950.
2009
-
Focality of Neural Stimulation with Magnetic Seizure Therapy (MST) and Electroconvulsive Therapy (ECT) in Humans and Non-Human Primates.
65:219S-220S.
2009
-
Homeostatic Imbalance of Purine Catabolism in First-Episode Neuroleptic-Naive Patients with Schizophrenia.
65:65S-65S.
2009
-
Individual differences in typical reappraisal use predict amygdala and prefrontal responses..
65:367-373.
2009
-
Abnormalities in Inflammatory Lipid Levels in First Episode Schizophrenic Patients are Modulated by Risperidone.
65:170S-170S.
2009
-
Metabolomics: A Global Biochemical Approach to the Study of Neuropsychiatric Disorders.
65:79S-79S.
2009
-
Interleukin-6 covaries inversely with hippocampal grey matter volume in middle-aged adults..
64:484-490.
2008
-
Serotonin transporter (5-HTTLPR) genotype and amygdala activation: a meta-analysis..
63:852-857.
2008
-
Dopaminergic role in cannabis-induced psychosis? Genetic and imaging evidence.
63:153S-153S.
2008
-
A Randomized controlled trial of venlafaxine ER versus placebo in pediatric social anxiety disorder..
62:1149-1154.
2007
-
Advances in the pharmacotherapy of attention-deficit/hyperactivity disorder..
62:951-953.
2007
-
Revisiting the backward masking deficit in schizophrenia: individual differences in performance and modeling with transcranial magnetic stimulation..
62:793-799.
2007
-
Resting state cortical connectivity reflected in EEG coherence in individuals with autism..
62:270-273.
2007
-
Risperidone and cognitive function in children with disruptive behavior disorders..
62:226-234.
2007
-
The use of prazosin for the treatment of trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder..
61:925-927.
2007
-
NCAM1 and neurocognition in schizophrenia..
61:902-910.
2007
-
Serotonin transporter genotype (5-HTTLPR): effects of neutral and undefined conditions on amygdala activation..
61:1011-1014.
2007
-
Errata.
61:826-826.
2007
-
Early pharmacological treatment of autism: a rationale for developmental treatment..
61:521-537.
2007
-
Rate of head growth decelerates and symptoms worsen in the second year of life in autism..
61:458-464.
2007
-
Cognitive behavioral treatment for young children with obsessive-compulsive disorder..
61:337-343.
2007
-
Facial expressions of emotion reveal neuroendocrine and cardiovascular stress responses..
61:253-260.
2007
-
Dorsolateral prefrontal cortex and anterior cingulate cortex white matter alterations in late-life depression..
60:1356-1363.
2006
-
Psychiatric disease in the twenty-first century: The case for subcortical ischemic depression..
60:1299-1303.
2006
-
Reply.
60:1382-1383.
2006
-
The neurosteroid allopregnanolone is reduced in prefrontal cortex in Alzheimer's disease..
60:1287-1294.
2006
-
Prefrontal-hippocampal coupling during memory processing is modulated by COMT val158met genotype..
60:1250-1258.
2006
-
Mood alters amygdala activation to sad distractors during an attentional task..
60:1139-1146.
2006
-
Human choline transporter gene variation is associated with corticolimbic reactivity and autonomic-cholinergic function..
60:1155-1162.
2006
-
Prevalence, clinical correlates, and longitudinal course of severe mood dysregulation in children..
60:991-997.
2006
-
Cerebellar volumes in pediatric maltreatment-related posttraumatic stress disorder..
60:697-703.
2006
-
Cognitive function in late life depression: relationships to depression severity, cerebrovascular risk factors and processing speed..
60:58-65.
2006
-
Algorithms and collaborative-care systems for depression: are they effective and why? A systematic review..
59:1029-1038.
2006
-
Attrition in randomized controlled clinical trials: methodological issues in psychopharmacology..
59:1001-1005.
2006
-
Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder..
59:1052-1060.
2006
-
Special Issue on Therapeutics.
59:989.
2006
-
Advancing the boundaries of molecular imaging..
59:881-882.
2006
-
Imaging genetics: perspectives from studies of genetically driven variation in serotonin function and corticolimbic affective processing..
59:888-897.
2006
-
An evaluation of the quick inventory of depressive symptomatology and the hamilton rating scale for depression: a sequenced treatment alternatives to relieve depression trial report..
59:493-501.
2006
-
Segmented hippocampal volume in children and adolescents with posttraumatic stress disorder..
59:523-529.
2006
-
Evidence for impaired cortical inhibition in patients with unipolar major depression..
59:395-400.
2006
-
Use of bupropion in combination with serotonin reuptake inhibitors..
59:203-210.
2006
-
Long-term neurocognitive effects of olanzapine or low-dose haloperidol in first-episode psychosis..
59:97-105.
2006
-
A randomized trial of citalopram versus placebo in outpatients with asthma and major depressive disorder: a proof of concept study..
58:865-870.
2005
-
Facial expressions of emotion reveal neuroendocrine and cardiovascular stress responses..
58:743-750.
2005
-
Maintaining a Steady Course: One of the "hottest Journals of the Millennium...".
58:433-434.
2005
-
A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression..
58:364-373.
2005
-
Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study..
58:355-363.
2005
-
Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial..
58:347-354.
2005
-
Aging-related diagnostic variations: need for diagnostic criteria appropriate for elderly psychiatric patients..
58:265-271.
2005
-
Prominent reduction in pyramidal neurons density in the orbitofrontal cortex of elderly depressed patients..
58:297-306.
2005
-
Mood disorders in the medically ill: scientific review and recommendations..
58:175-189.
2005
-
Through the looking glass: risk perception..
57:1477-1478.
2005
-
Variation of human amygdala response during threatening stimuli as a function of 5'HTTLPR genotype and personality style..
57:1517-1525.
2005
-
Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction..
57:1117-1127.
2005
-
Bupropion XL in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled study..
57:793-801.
2005
-
Antidepressant-like effects of cranial stimulation within a low-energy magnetic field in rats..
57:571-576.
2005
-
Defining a cognitive function decrement in schizophrenia..
57:688-691.
2005
-
Experimental therapeutics and biological psychiatry.
57:695.
2005
-
Antidepressant-like effects of uridine and omega-3 fatty acids are potentiated by combined treatment in rats..
57:343-350.
2005
-
Psychosocial context of antidepressant response..
57:314.
2005
-
Early developmental exposure to methylphenidate reduces cocaine-induced potentiation of brain stimulation reward in rats..
57:120-125.
2005
-
Perfusion abnormalities and decision making in cocaine dependence..
56:527-530.
2004
-
Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria..
56:301-307.
2004
-
Chronic very low dose naltrexone administration attenuates opioid withdrawal expression..
56:261-268.
2004
-
One-year clinical outcomes of depressed public sector outpatients: a benchmark for subsequent studies..
56:46-53.
2004
-
Hippocampal volume, spectroscopy, cognition, and mood in patients receiving corticosteroid therapy..
55:538-545.
2004
-
Testosterone, antisocial behavior, and social dominance in boys: pubertal development and biosocial interaction..
55:546-552.
2004
-
Clinical characteristics of magnetic resonance imaging-defined subcortical ischemic depression..
55:390-397.
2004
-
Diffusion tensor imaging: background, potential, and utility in psychiatric research..
55:201-207.
2004
-
Enduring behavioral effects of early exposure to methylphenidate in rats..
54:1330-1337.
2003
-
Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression..
54:806-817.
2003
-
A magnetic resonance spectroscopic imaging study of adult nonhuman primates exposed to early-life stressors..
54:727-735.
2003
-
Apolipoprotein E genotype and subcortical vascular lesions in older depressed patients and control subjects..
54:674-681.
2003
-
Focal and lateralized subcortical abnormalities in unipolar major depressive disorder: an automated multivoxel proton magnetic resonance spectroscopy study..
54:744-750.
2003
-
Erratum: The 16-item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): A psychometric evalution in patients with chronic major depression (Biological Psychiatry 54 (573-583)).
54:585.
2003
-
Subcortical lesion severity and orbitofrontal cortex volume in geriatric depression..
54:529-533.
2003
-
The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression..
54:573-583.
2003
-
Predicting suicidal risk in schizophrenic and schizoaffective patients in a prospective two-year trial..
54:444-452.
2003
-
Depression and cardiovascular disease: mechanisms of interaction..
54:248-261.
2003
-
Persistent pain and depression: a biopsychosocial perspective..
54:399-409.
2003
-
Neocortical modulation of the amygdala response to fearful stimuli..
53:494-501.
2003
-
Physiologic impairment of olfactory stimulus processing in schizophrenia..
53:403-411.
2003
-
Effectiveness of chromium in atypical depression: a placebo-controlled trial..
53:261-264.
2003
-
Maternal smoking during pregnancy and risk to boys' conduct disturbance: an examination of the causal hypothesis..
53:130-135.
2003
-
Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial..
53:188-191.
2003
-
Smaller orbital frontal cortex volumes associated with functional disability in depressed elders..
53:144-149.
2003
-
Early physical and sexual abuse associated with an adverse course of bipolar illness..
52:843.
2002
-
Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia..
52:701-707.
2002
-
Comorbidity of depression with other medical diseases in the elderly..
52:559-588.
2002
-
Comorbidity of late life depression: an opportunity for research on mechanisms and treatment..
52:543-558.
2002
-
Development and natural history of mood disorders..
52:529-542.
2002
-
Skating to where the puck is going to be: a plan for clinical trials and translation research in mood disorders..
52:631-654.
2002
-
Biological risk factors in late life depression..
52:185-192.
2002
-
An application of the revised CONSORT standards to FDA summary reports of recently approved antidepressants and antipsychotics..
52:62-67.
2002
-
APOE genotype and hippocampal volume change in geriatric depression..
51:426-429.
2002
-
Early physical and sexual abuse associated with an adverse course of bipolar illness..
51:288-297.
2002
-
High rate of autoimmune thyroiditis in bipolar disorder: lack of association with lithium exposure..
51:305-311.
2002
-
Vagus nerve stimulation (VNS) for major depressive episodes: one year outcomes..
51:280-287.
2002
-
Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination..
51:123-133.
2002
-
Sensitization to the cardiovascular but not subject-rated effects of oral cocaine in humans..
51:143-150.
2002
-
Cytokine effects on cortical neuron MAP-2 immunoreactivity: implications for schizophrenia..
50:743-749.
2001
-
Strengthening clinical effectiveness trials: equipoise-stratified randomization..
50:792-801.
2001
-
Performance feedback deficit in geriatric depression..
50:358-363.
2001
-
MRI correlates of suicide attempt history in unipolar depression..
50:266-270.
2001
-
Evidence of white matter tract disruption in MRI hyperintensities..
50:179-183.
2001
-
Reply.
50:69-69.
2001
-
Specific psychotherapies for childhood and adolescent depression..
49:1091-1100.
2001
-
Medial orbital frontal lesions in late-onset depression..
49:803-806.
2001
-
Sham TMS: intracerebral measurement of the induced electrical field and the induction of motor-evoked potentials..
49:460-463.
2001
-
Elevated motor threshold in drug-free, cocaine-dependent patients assessed with transcranial magnetic stimulation..
49:369-373.
2001
-
Cognitive effects of nicotine..
49:258-267.
2001
-
Reduction of orbital frontal cortex volume in geriatric depression..
48:971-975.
2000
-
Methodological issues in developing new acute treatments for patients with bipolar illness..
48:615-624.
2000
-
Hippocampal volume in geriatric depression..
48:301-309.
2000
-
Inhibitory control in children with attention-deficit/hyperactivity disorder: event-related potentials identify the processing component and timing of an impaired right-frontal response-inhibition mechanism..
48:238-246.
2000
-
Olanzapine increases allopregnanolone in the rat cerebral cortex..
47:1000-1004.
2000
-
Efficient trial designs to reduce placebo requirements..
47:724-726.
2000
-
The use of placebos in unipolar major depression: the current status..
47:745-747.
2000
-
34. Serotonin transporter genotypes, CSF 5HIAA, and cardiovascular reactivity to stress.
47:S10-S10.
2000
-
410. Interactive effects in the anterior cingulate of sadness and selective attention: a PET study.
47:S125-S126.
2000
-
456. Cortical excitability in cocaine-dependent subjects; preliminary data.
47:S139-S139.
2000
-
Sleep electroencephalographic coherence abnormalities in individuals at high risk for depression: a pilot study..
47:618-625.
2000
-
Ultradian rhythms and temporal coherence in sleep EEG in depressed children and adolescents..
47:338-350.
2000
-
Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study..
47:276-286.
2000
-
Vagus nerve stimulation: a new tool for brain research and therapy..
47:287-295.
2000
-
Smoking and therapeutic response to clozapine in patients with schizophrenia..
46:125-129.
1999
-
A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder..
45:1226-1229.
1999
-
Hyperintense lesions on magnetic resonance images in bipolar disorder..
45:965-971.
1999
-
Prolactin response to electroconvulsive therapy..
45:378-381.
1999
-
Prolactin response to electroconvulsive therapy - Response.
45:379-381.
1999
-
Generalized anxiety disorder: neurobiological and pharmacotherapeutic perspectives..
44:1286-1294.
1998
-
Toward a generalizable model of symptoms in major depressive disorder..
44:959-972.
1998
-
Adrenergic receptors in premenstrual dysphoric disorder: I. Platelet alpha 2 receptors: Gi protein coupling, phase of menstrual cycle, and prediction of luteal phase symptom severity..
44:600-609.
1998
-
Effects of electroconvulsive therapy on plasma vasopressin and oxytocin..
44:610-616.
1998
-
Magnetic resonance imaging correlates of depression in early- and late-onset Alzheimer's disease..
44:592-599.
1998
-
Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder..
44:3-14.
1998
-
Ventricular enlargement in poor-outcome schizophrenia..
43:783-793.
1998
-
Structural neuroimaging and mood disorders: recent findings, implications for classification, and future directions..
43:705-712.
1998
-
196. Onset of alzheimer's disease in susceptible subjects: Influence of APOE.
43:S58-S58.
1998
-
Effects of electroconvulsive therapy in adolescents with severe endogenous depression resistant to pharmacotherapy..
43:335-338.
1998
-
Whole blood serotonin relates to violence in an epidemiological study..
43:446-457.
1998
-
Prolactin response to electroconvulsive therapy: effects of electrode placement and stimulus dosage..
43:146-155.
1998
-
A repeat proton magnetic resonance spectroscopy study in social phobia..
42:419-424.
1997
-
Clozapine-induced electroencephalogram changes as a function of clozapine serum levels..
42:132-137.
1997
-
Dexamethasone response, thyrotropin-releasing hormone stimulation, rapid eye movement latency, and subtypes of depression..
41:915-928.
1997
-
Effect of nitrous oxide on cerebral blood velocity while reclining and standing..
41:979-984.
1997
-
A twin study of late-onset depression and apolipoprotein E epsilon 4 as risk factors for Alzheimer's disease..
41:851-856.
1997
-
Cerebral vasodilation and vasoconstriction associated with acute anxiety..
41:782-795.
1997
-
EEG correlates of the response to ECT.
41:189-189.
1997
-
Response.
41:912-913.
1997
-
Serotonin transporter expression in rat brain regions and blood platelets: aging and glucocorticoid effects..
41:172-183.
1997
-
A study of the potential confounding effects of diet, caffeine, nicotine and lorazepam on the stability of plasma and urinary homovanillic acid levels in patients with schizophrenia..
40:1218-1221.
1996
-
Effects of four normalizing methods on data analytic results in functional brain imaging..
40:1106-1121.
1996
-
Empirical evaluation of the factorial structure of clinical symptoms in schizophrenia: effects of typical neuroleptics on the brief psychiatric rating scale..
40:755-760.
1996
-
Acute changes in cranial blood flow after cocaine hydrochloride..
40:609-616.
1996
-
Do glucocorticoids contribute to the abnormalities in serotonin transporter expression and function seen in depression? An animal model..
40:576-584.
1996
-
National Institute of Mental Health Workshop Report on the Treatment of Bipolar Disorder..
40:215-220.
1996
-
Apolipoprotein E-epsilon 4 frequency in geriatric depression..
40:69-71.
1996
-
Impact of neuroleptic medications on continuous performance test measures in schizophrenia..
39:902-905.
1996
-
Cognitive impairment in elderly depressed individuals with APOE epsilon 4.
39:539-539.
1996
-
Prolactin response to ect: Effects of electrode placement and dosage.
39:649-649.
1996
-
Impulsivity and neuroendocrine response to buspirone in bulimia nervosa..
39:371-374.
1996
-
Plasma GABA predicts acute response to divalproex in mania..
39:278-284.
1996
-
Brain fluoxetine measurements using fluorine magnetic resonance spectroscopy in patients with social phobia..
38:696-698.
1995
-
Benzodiazepines as antidepressants: does GABA play a role in depression?.
38:578-591.
1995
-
Arecoline reverses dexamethasone suppression of cortisol in normal males: a pilot study..
37:811-816.
1995
-
Seizure threshold in electroconvulsive therapy (ECT) II. The anticonvulsant effect of ECT..
37:777-788.
1995
-
Stability of plasma GABA at four-year follow-up in patients with primary unipolar depression..
37:806-810.
1995
-
Seizure threshold in electroconvulsive therapy: I. Initial seizure threshold..
37:713-720.
1995
-
Clozapine decreases smoking in patients with chronic schizophrenia..
37:550-552.
1995
-
Influence of L-triiodothyronine on memory following repeated electroconvulsive shock in rats: implications for human electroconvulsive therapy..
37:198-201.
1995
-
Do anticonvulsants hinder clozapine treatment?.
37:132-133.
1995
-
Sleep EEG features of adolescents with major depression..
36:573-581.
1994
-
Age dependent change of ventricular measures in schizophrenia: Cross-sectional analysis.
35:704-705.
1994
-
Fetal brain development of twins assessedIn utero by ultrasound.
35:623-623.
1994
-
Longitudinal classification in schizophrenia: The relationship between kraepelinian and deficit syndrome subtypologies.
35:695-695.
1994
-
Neuroleptic effects on CPT and eye tracking in schizophrenia.
35:674-674.
1994
-
Working memory dysfunction in Kraepelinian schizophrenics.
35:660-660.
1994
-
A pilot study of a structured interview addressing sexual function in men with schizophrenia..
35:32-35.
1994
-
The effects of ECT stimulus dose and electrode placement on the ictal electroencephalogram: an intraindividual crossover study..
34:759-767.
1993
-
Convulsive threshold differences in right unilateral and bilateral ECT..
34:606-611.
1993
-
Asymmetry of rCBF in schizophrenia: relationship to AP-gradient and duration of illness..
33:806-814.
1993
-
Depersonalization after marijuana smoking..
33:431-441.
1993
-
The dexamethasone suppression test and quantitative cerebral anatomy in depression..
33:442-449.
1993
-
Spectral and topographic analysis of EEG in schizophrenic patients..
33:284-290.
1993
-
Low plasma gamma-aminobutyric acid levels in male patients with depression..
32:354-363.
1992
-
Changes in middle cerebral artery velocity after marijuana..
32:164-169.
1992
-
Genetic animal models of depression and ethanol preference provide support for cholinergic and serotonergic involvement in depression and alcoholism..
31:919-936.
1992
-
Changes in cerebral blood velocity after intravenous diazepam..
31:690-697.
1992
-
Subcortical brain anatomy in anorexia and bulimia..
31:735-738.
1992
-
EEG evidence of more "intense" seizure activity with bilateral ECT..
31:617-621.
1992
-
Digital period analysis of sleep EEG in depression..
31:52-68.
1992
-
Magnetic resonance findings in patients with early-onset Alzheimer's disease..
29:799-810.
1991
-
Platelet [3H]-imipramine binding and leukoencephalopathy in geriatric depression..
29:665-670.
1991
-
MRI of corpus callosum and septum pellucidum in depression..
29:300-301.
1991
-
Cardiovascular response to unilateral electroconvulsive therapy..
28:758-766.
1990
-
A cross-sectional study of the effects of depression on REM latency..
28:697-704.
1990
-
Comparison of urinary-free cortisol in depressed and nondepressed patients with malignancy..
28:522-525.
1990
-
Cerebral white matter disease in late-onset paranoid psychosis..
28:266-274.
1990
-
A brain magnetic resonance imaging study of pituitary gland morphology in anorexia nervosa and bulimia..
28:110-116.
1990
-
Hunger in humans induced by MK-329, a specific peripheral-type cholecystokinin receptor antagonist..
28:169-173.
1990
-
Nocturnal and early morning secretion of ACTH and cortisol in humans..
28:47-57.
1990
-
Adrenocortical sensitivity to low-dose ACTH administration in depressed patients..
27:930-933.
1990
-
Age-adjusted threshold values for reduced REM latency in unipolar depression using ROC analysis..
27:841-853.
1990
-
Plasma dexamethasone concentrations and the dexamethasone suppression test..
27:159-173.
1990
-
Neuroanatomical changes and hypothalamo-pituitary-adrenal axis abnormalities..
26:729-732.
1989
-
The prevalence of periodic limb movements during sleep in men with erectile dysfunction..
26:541-544.
1989
-
The corticotropin-releasing hormone test in patients with posttraumatic stress disorder..
26:349-355.
1989
-
Abnormalities in the response of plasma arginine vasopressin during hypertonic saline infusion in patients with eating disorders..
26:73-86.
1989
-
Differential sensitivity to dexamethasone suppression in an animal model of the DST..
26:26-34.
1989
-
Reduced REM latency predicts response to tricyclic medication in depressed outpatients..
26:61-72.
1989
-
Reduced inhibitory effect of imipramine on radiolabeled serotonin uptake into platelets in geriatric depression..
25:687-691.
1989
-
Sleep EEG in bulimic, depressed, and normal subjects..
25:661-664.
1989
-
Depression in early-onset Alzheimer's disease: clinical and neuroendocrine correlates..
24:937-940.
1988
-
MRI scans in patients with tardive dyskinesia..
24:852-857.
1988
-
Leukoencephalopathy in elderly depressed patients referred for ECT..
24:143-161.
1988
-
Adrenocortical sensitivity to ACTH in humans..
24:105-108.
1988
-
Topographic maps of brain electrical activity--pitfalls and precautions..
23:628-636.
1988
-
Leukoencephalopathy in patients diagnosed as major depressive..
23:519-522.
1988
-
CSF corticotropin-releasing factor-like immunoactivity in chronic pain patients with and without major depression..
23:86-88.
1988
-
ECT instrumentation.
24:361.
1988
-
Effect of gamma interferon on the hypothalamic-pituitary-adrenal system..
22:1163-1166.
1987
-
Elevated hematocrit in patients with schizophrenia..
22:907-910.
1987
-
Polysomnographic findings and dexamethasone nonsuppression in unipolar depression: a replication and extension..
22:872-882.
1987
-
REM latency concordance in depressed family members..
22:910-914.
1987
-
The effect of lithium on the membrane molecular dynamics of normal human erythrocytes..
22:857-871.
1987
-
Organic affective disorder in a patient with congenital adrenal hyperplasia..
22:767-770.
1987
-
Augmentation of ECT seizures with caffeine..
22:637-649.
1987
-
Diagnostic utility of the dexamethasone suppression test..
22:618-628.
1987
-
Electroconvulsive therapy of depression in patients with white matter hyperintensity..
22:629-636.
1987
-
Response.
22:1047-1048.
1987
-
Sleep parameters in bipolar I, bipolar II, and unipolar depressions..
21:1340-1343.
1986
-
Which endogenous depressive symptoms relate to REM latency reduction?.
21:473-482.
1986
-
Response.
21:428.
1986
-
Response.
21:428-.
1986
-
Response.
21:576-577.
1986
-
Free triiodothyronine (T3) and thyroxine (T4) in a group of unipolar depressed patients and normal subjects..
20:1047-1054.
1985
-
Weight change and the dexamethasone suppression test..
20:1018-1022.
1985
-
What does the dexamethasone suppression test identify?.
20:957-964.
1985
-
Platelet alpha-2-adrenergic dysfunction in negative symptom schizophrenia: a preliminary study..
20:539-545.
1985
-
ECT-induced amnesia and postictal EEG suppression..
20:344-348.
1985
-
The dexamethasone suppression test in borderline personality disorder..
19:1149-1153.
1984
-
Effects of single and repeated alcohol withdrawal on kindling..
19:525-537.
1984
-
The effect of isocarboxazid on platelet MAO activity..
18:1075-1079.
1983
-
Cortisol, estradiol, and androgens in acutely ill paranoid schizophrenics..
18:583-590.
1983
-
Autobiographical amnesia with ECT: an analysis of the roles of stimulus wave form, electrode placement, stimulus energy, and seizure length..
18:121-126.
1983
-
Relationship of dysfunctional attitudes and dexamethasone response in endogenous and nonendogenous depression..
17:1303-1314.
1982
-
The effects of ECT modifications on autobiographical and verbal memory..
17:919-924.
1982
-
Sleep EEG and dexamethasone suppression test findings in outpatients with unipolar major depressive disorders..
17:327-341.
1982
-
ECT and seizure threshold: effects of stimulus wave form and electrode placement..
15:225-241.
1980
-
Catechol-O-methyltransferase activity and classification of depression..
14:937-942.
1979
-
Testosterone-attenuated stereotype and hyperactivity induced by beta-phenylethylamine in pargyline-pretreated rats..
13:455-463.
1978
-
Depressive Symptom Dimensions and Response Trajectories in Electroconvulsive Therapy and Magnetic Seizure Therapy
2022
-
Psychological Functioning, Neurosteroids, and White Matter Microstructure in the Context of Post-Traumatic Stress Disorder and Mild Traumatic Brain Injury
2022
-
Characteristics of Patients Who Received Deep Brain Stimulation in Obsessive-Compulsive Disorder Versus Major Depressive Disorder
2021
-
Comparison of Prolactin and Cortisol Response to Magnetic Seizure Therapy and Electroconvulsive Therapy
2021
-
ECT-Lithium Combination is Associated With Less Cognitive Impairment in Bipolar Depression Compared to Unipolar: Could This Also Support the Biological Difference Between the 2 Types of Depression?
2021
-
Acute Stress in Children and Adolescents: Developing Autonomic, Endocrine, and Neural Responses
2020
-
All-Cause Mortality is Lower in Major Depressive Disorder (MDD) Patients Who Had ECT Compared to Non-ECT in a National Sample of 949,394 Inpatients
2020
-
Corticocortical Evoked Potentials and Patient Response Reveal Networks Underlying Depression
2020
-
Deficits in Auditory Predictive Coding in Individuals With the Psychosis Risk Syndrome: Prediction of Conversion to Psychosis
2020
-
Factor Structure of the Hamilton Depression Rating Scale During Electroconvulsive Therapy and Magnetic Seizure Therapy in the Treatment of Major Depression
2020
-
Gamma Oscillations and Excitation/Inhibition Imbalance: Parallel Effects of NMDA Receptor Antagonism and the Psychosis Risk Syndrome
2020
-
Neuroendocrine Responses to Acute Psychosocial Stress are Predictive of Cognitive Disorganization in Adolescents
2020
-
Optimizing the Effects of Theta-Burst Stimulation (TBS)
2020
-
Reproductive Hormones Regulate Affect and Reward Circuit Function in Women
2020
-
Sex Differences in Conditioned Taste Aversion
2020
-
The Impact of Acute Stress on Dynamic Neural Circuits in Adolescence: Relationships to Psychosis-Related Symptomatology and Development
2020
-
The Microbiome-Immune-Brain Axis and Cognitive Side Effects of Electroconvulsive Therapy
2020
-
Using Mnemonic Similarity Task to Assess Medial Temporal Lobe Function: A Magnetoencephalography Study
2020
-
108. Hippocampal Subfield Volumes Relate to Unique Phenotypes of PTSD: International Analysis by the PGC-ENIGMA PTSD Working Group
2019
-
116. Results of the NIMH FAST-MAS Phase IIa Proof of Mechanism Study of the Effects of the Selective κ Opioid Antagonist JNJ-67953964 on fMRI Ventral Striatal Activity in Anhedonic Patients
2019
-
139. Methlyome-Wide Changes Associated With Childhood Trauma and its Long-Term Outcomes
2019
-
144. Cognitive Neurostimulation: Volitional Regulation of Ventral Tegmental Area
2019
-
F14. Neurostimulation Enhanced Cognitive Restructuring: A Proof of Concept Study
2019
-
F2. White Matter Lesions are Common in Midlife and Associated With Cognitive Decline
2019
-
O46. A National Study for Regional Variation of Inpatient ECT Utilization From 4,411 Hospitals Across the United States
2019
-
S112. A Spectral Method for Determining Cortical Silent Period Induced by Transcranial Magnetic Stimulation
2019
-
S57. Does the Acquisition of Social Cognitive Skills Over Adolescence Coincide With Neurophysiological Metric of Brain Maturation? A Cross-Sectional Analysis of the NAPLS-II Consortium Sample
2019
-
S7. General Functional Connectivity: Shared Features of Resting State and Task fMRI Drive Reliable and Heritable Individual Differences in Functional Brain Networks
2019
-
T126. Short- Vs Medium + Long-Chain Plasma Acylcarnitine in Phenotypes of Major Depression at Baseline and After Citalopram/Escitalopram Treatment
2019
-
T15. Repetitive Transcranial Magnetic Stimulation Reveals a Causal Link Between Right dlPFC Activity and Anxiety Expression
2019
-
T91. Deep Brain Stimulation for Depressive Episodes: A National Study for Regional Variation of Utilization Across the United States
2019
-
F113. Hippocampal Connectivity Insulates High-Risk Adolescents From the Relationship Between Stress and Depressive Symptoms
2018
-
S147. Resting-State EEG Source Analysis in Depressed Patients Treated With Electroconvulsive Therapy and Magnetic Seizure Therapy
2018
-
T157. Using Real-Time fMRI Neurofeedback as a Tool for Demonstrating Therapeutic Efficacy
2018
-
T176. Controllability of Structural Brain Networks in Depressed Patients Receiving Repetitive Transcranial Magnetic Stimulation
2018
-
4. Transforming Mental Health Treatment through Innovation in Tools, Targets, and Trials
2017
-
641. Neurocognitive Predictors of Antidepressant Efficacy to Transcranial Direct Current Stimulation: Results from an International Randomized Controlled Trial
2017
-
644. Neurocognitive Effects of Transcranial Direct Current Stimulation (tDCS) in Unipolar and Bipolar Depression: Results from an International Randomized Controlled Trial
2017
-
73. Efficacy of Transcranial Direct Current Stimulation in Unipolar and Bipolar Depression: Results from an International Randomized Controlled Trial
2017
-
A Unique Dual Cortico-Striatal Action of a Beta-Arrestin Biased Dopamine D2 Receptor Ligand
2016
-
Cognitive Behavioral Strategies During Transcranial Magnetic Stimulation in Obsessive-Compulsive Disorder
2016
-
Epigenome-Wide Association of PTSD from Heterogeneous Cohorts with a Common Multi-Site Analysis Pipeline
2016
-
Genome-Wide Association of Neuroimaging Phenotypes in PTSD at Multiple Sites
2016
-
Neural Mechanisms of Emotion Regulation in Major Depression and Implications for Psychotherapy Effectiveness
2016
-
Re-evaluating the Electroconvulsive Therapy Stimulus: Train Duration
2016
-
From Circuits to the Clinic: Bridging Systems Neuroscience with the Practice of Psychiatry through Neuromodulation
2016
-
Assessment of Myelin Compromise in Mild Traumatic Brain Injury with Quantitative Susceptibility Mapping
2015
-
Association of Obesity and Levels of Inflammatory Markers on Treatment Outcome with Adjunctive (6S)-5-methyl-5,6,7,8-tetrahydropteroyl-L-glutamic Acid (CH3-FH4) in MDD Patients Who are Inadequate Responders to SSRIs
2015
-
Can We Use Brain Oscillations to Guide Treatment of MDD?
2015
-
Endurance of Neural Response to Rewards Predicts Post-Treatment Depression Severity
2015
-
Ictal EEG Correlates of Neurocognitive Outcome in Electroconvulsive Therapy and Magnetic Seizure Therapy
2015
-
Positive Correlation Between Nightmares and Heart Rate Response to Loud Tones Supports Parasympathetic Dysfunction in Posttraumatic Stress Disorder
2015
-
Re-evaluating the Electroconvulsive Therapy Stimulus: Frequency and Directionality
2015
-
Restored WAVE1 Levels in a Model of NMDA Receptor Hypofunction Attenuates Working Memory Deficits
2015
-
Walking Corpse Syndrome Presenting With Catatonia: Case Report and Literature Review
2015
-
Effectiveness of Synchronized Transcranial Magnetic Stimulation (sTMS) for Treatment of Major Depression
2014
-
Fear Learning Circuitry in PTSD is Biased Toward Generalization of Conditioned Response
2014
-
Individualized Low Amplitude Seizure Therapy (iLAST) - Magnetic and Electric Approaches to Enhance Focality and Safety for Depression Treatment
2014
-
The Impact of Eszopiclone Insomnia Treatment on Cognition in Schizophrenia: A Double-blind, Randomized, Placebo-controlled Trial
2014
-
Ultrabrief Right Unilateral ECT in Geriatric Depression: Antidepressant and Cognitive Outcomes
2014
-
A Multi-Site, Naturalistic Study of RTMS for Major Depressive Disorder
2013
-
A Pilot Study of Neuroplasticity Based Cognitive Remediation in Adolescents with Psychosis
2013
-
Childhood Abuse and Cannabis Use Interact with the COMT Genotype to Predict Psychotic Symptoms in the General Population
2013
-
Diffusion Tensor Imaging of OEF/OIF Veterans with and without Exposure to Primary Blast Forces
2013
-
Lateralized Effects of Prefrontal Transcranial Magnetic Stimulation on Emotional Working Memory
2013
-
Network Analysis of Intrinsic Functional Organization of the Brain in Mild Traumatic Brain Injury
2013
-
Phosphorylation of MeCP2 in Reward-Related Circuits is Required for Amphetamine-Induced Conditioned Place Preference in Mice
2013
-
Pilot Study of Sustained Oxytocin Treatment in Children and Adolescents with Autistic Disorder
2013
-
Pregnenolone Rescues Schizophrenia-Like Behavior in Dopamine Transporter Knockout Mice
2013
-
Vulnerability or Consequence: Amygdala Volume Changes with PTSD in a Large Case-Controlled Veteran Group
2013
-
BDNF Gene Polymorphism (Val66Met) Predicts Amygdala and Hippocampus Activation in Children Diagnosed with Anxiety as Preschoolers
2012
-
Neuroactive Steroids Enhance Activation of Emotion Regulation Brain Circuits
2012
-
Randomized, Double-Blind, Placebo Controlled, Parallel Group Exploratory Study of GSK239512 for Cognitive Impairment in Stable Schizophrenia Subjects on Background Antipsychotic Therapy
2012
-
Resting State Connectivity Between Amygdalar Subregions and the Prefrontal Cortex is Disrupted in PTSD
2012
-
Sex Differences in Early-Life Programming of Neuroinflammation and Behavioral Abnormalities by High Fat Diet
2012
-
A Test of Causal Hypotheses of Psychopathic Traits: Reduced Emotional Responsiveness or Anomalous Attentional Control?
2011
-
Clinical Predictors of White Matter Disruption in Chronic Mild Traumatic Brain Injury among Post-9/11 Veterans
2011
-
Genotypic Differences in Angiotensin Receptor Genes in Late-Life Depression
2011
-
Reduced Amygdala and Hippocampal Volumes Associated with PTSD in Recent Military Veterans from Iraq and Afghanistan
2011
-
Repetitive Transcranial Magnetic Stimulation (rTMS) of the Superior Frontal Gyrus Modulates Craving for Cigarettes
2011
-
Stress Vulnerability Moderates the Association between White Matter Lesions and Late-Life Depression
2011
-
Associations between Purine Metabolites and Clinical Symptoms in Schizophrenia
2011
-
CRP and Depression: A Test of Alternative Hypotheses
2010
-
Daily Left Prefrontal TMS for Major Depression: A Sham-Controlled Multi-Site Randomized Trial (NIH Optimization of TMS for Depression Study, OPT-TMS)
2010
-
Effect of Supplementary Motor Area Modulation on Motor Cortex Excitability in Obsessive-Compulsive Disorder: Relations to Clinical Improvement
2010
-
Modulation Effect of Rumination Trait and Low Tryptophan on Default-Mode Network Connectivity
2010
-
Proof-of-Concept Randomized Controlled Trial with Pregnenolone in Mild Traumatic Brain Injury
2010
-
Regulatory Focus and Reward Sensitivity: Integrating Social-Cognitive and Affective Neuroscience Perspectives
2010
-
Reversal of Consolidated Behavioral Sensitization and Associated Neurochemical Changes by Local Infusion of PKC Zeta (zeta) Inhibitory Pseudosubstrate (ZIP) Peptide in Nucleus Accumbens Core
2010
-
Static and Dynamic Cognitive Deficits in Childhood Precede Adult Schizophrenia: A 30-Year Study
2010
-
Temporo-Parietal Junction Stimulation in the Treatment of Depersonalization Disorder
2010
-
Translational Development of Novel Pharmacotherapeutic Strategies for Psychostimulant Dependence
2010
-
Dopamine's Role in ADHD Symptoms: Beyond an Attention Deficit
2010
-
Effects of Guanfacine Extended Release in Children Aged 6 to 12 Years with Oppositional Symptoms and a Diagnosis of Attention-Deficit/Hyperactivity Disorder
2010
-
Response to Guanfacine Extended Release in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD)
2010
-
Differentiation of Reward Dependent Behavior Circuitry from Reward Anticipation with fMRI-Guided TMS
2009
-
Frequency-Dependent Effects of rTMS on Neurogenesis, Synaptic Plasticity, and Behavior
2009
-
Frontal Cortex GABA and Glutamate-Glutamine Levels in Schizophrenia Measured with Magnetic Resonance Spectroscopy
2009
-
Analgesic efficacy of milnacipran in animal models of chronic pain
2008
-
Atypical antipsychotic drugs and diabetes mellitus in the USFDA adverse event reporting system (AERS) database in pediatric and adult patients
2008
-
Brain activation during decisions involving behavioral risk: Adolescents v. adults
2008
-
Cognitive and sedative effects of guanfacine extended release in children and adolescents aged 6 to 17 years with attention-deficit/hyperactivity disorder: Safety and sleep effects
2008
-
Functional neuroimaging of social and executive processes in individuals with autism
2008
-
High dose magnetic seizure therapy (HD-MST) increases mossy fiber sprouting but not cellular proliferation in the primate dentate gyrus
2008
-
L-serine predicts self-reported pain in female OEF/OIF veterans
2008
-
Randomized sham controlled trial of transcranial magnetic stimulation (TMS) to the supplementary motor area (SMA) for the treatment of medication resistant obsessive-compulsive disorder (OCD)
2008
-
Trauma-related distractors modulate neural systems for working memory in posttraumatic stress disorder
2008
-
fMRI-guided rTMS in the remediation of sleep deprivation-induced performance deficits ina working memory task
2008
-
Discriminative tryptophan pathway in first-episode neuroleptic-naive patients with schizophrenia
2008
-
Metabolomics and lipidomics of neuropsychiatric disorders: Emerging data
2008
-
Cerebrospinal fluid DHEA levels are elevated in Alzheimer's disease, related to neuropathological disease stage, and correlated with brain DHEA levels
2007
-
Cognitive improvement correlates with weight gain in schizophrenia subjects receiving quetiapine but not other antipsychotics: Data from the CATIE trial
2007
-
Effect of electroconvulsive shock and magnetic seizure on gene expression profiles in the prefrontal cortex of the rhesus monkey
2007
-
Effect of electroconvulsive shock and magnetic seizure on gene expression profiles in the prefrontal cortex of the rhesus monkey
2007
-
Frontiers in TMS technology development: Controllable pulse shape TMS (cTMS) and magnetic seizure therapy (MST) at 100 Hz
2007
-
Metabolomic mapping of schizophrenia and atypical antipsychotic effects
2007
-
Neural systems for executive and emotional processing are modulated by level of posttraumatic stress disorder symptoms in Iraq war veterans
2007
-
Neuroactive steroids are related to psychiatric symptoms in veterans returning from iraq and Afghanistan
2007
-
Proof-of-concept trial with the neurosterold pregnenolone targeting neurocognitive and negative symptoms in schizophrenia
2007
-
Durability of acute response to TMS in the treatment of major depression: Relapse during a continuation pharmacotherapy extension study
2007
-
Safety and tolerability of TMS in the treatment of major depression: Evidence from extended exposure and reintroduction treatment
2007
-
Sleep outcomes following eszopiclone discontinuation in patients with primary insomnia co-existing with major depressive disorder or generalized anxiety disorder
2007
-
TMS in the acute treatment of major depression: Clinical response in an open-label extension trial
2007
-
TMS in the acute treatment of major depression: Improvements in functional status and quality of life
2007
-
Neurosteroids as candidate modulators of pathophysiology in Alzheimer's disease and nicotine dependence
2006
-
The effects of olanzapine, quetiapine, and risperidone on neurocognitive function in first-episode psychosis: A double-blind, 52-week comparison
2006
-
A pilot study of high frequency prefrontal rTMS for the treatment of the negative symptoms of schizophrenia
2006
-
GABA, genes and depression
2006
-
Immediate postictal effects of ECT on cerebral perfusion
2006
-
Network-dependent facilitation of cognitive task performance with rTMS
2006
-
Baseline neurocognitive assessment of 1364 patients with schizophrenia in the clinical antipsychotic trials for intervention effectiveness (CATIE) project
2005
-
Elevated plasma A beta(1-42) in geriatric depression
2005
-
Neuroactive steroid alterations in posterior cingulate and parietal cortex in subjects with schizophrenia and bipolar disorder: Potential gender specificity
2005
-
Neuroactive steroids and neurodegenerative disorders: Investigations in subjects with Alzheimer's and relevance to neuropathological disease stage
2005
-
Neuroactive steroids in schizophrenia, PTSD, and Alzheimer's disease: Relevance to pathophysiology and treatment
2005
-
Neuroactive steroids, mood stabilizers, and neuroplasticity: Alterations following lithium and changes in Bcl-2 knockout mice
2005
-
Effects of vagus nerve stimulation on cortical excitability in patients with major depression
2005
-
Performance on a working memory task can be differentially impaired or improved with rTMS stimulation of the precuneus: Frequency- and time-dependent effects
2005
-
Recent advances in the design of multisite clinical trials using transcranial magnetic stimulation
2005
-
Stereological and neuropathological examination of the safety of electroconvulsive shock (ECS) and magnetic seizure therapy (MST) in nonhuman primates
2005
-
Cognitive enhancement in schizophrenia: Ending the therapeutic nihilism
2004
-
Effect of olanzapine versus placebo on the neuropsychological status of prodromal subjects
2004
-
Neuroactive steroids in schizophrenia: Relevance to symptoms and therapeutics
2004
-
Neuronal pathology in orbitofrontal cortex in elderly subjects with MDD is more severe than that in age-matched control subjects
2004
-
Nicotinic receptor modulation of attention: An endophenotype for therapeutic drug development
2004
-
PET imaging of prefrontal dopamine D1 receptors in chronic ketamine human abusers: A model for schizophrenia
2004
-
The relationship of cognition changes and other symptoms following antipsychotic treatment
2004
-
Defining a cognitive function decrement in schizophrenia
2004
-
Evidence for impaired cortical inhibition in patients with unipolar major depression
2004
-
Hippocampal cellular proliferation and cognitive outcome following magnetic seizure therapy and electroconvulsive shock
2004
-
Hippocampal plasticity following ECT: Towards a theory of antidepressant action
2004
-
The spatial distribution of mossy fiber sprouting in a non-human primate model for electroconvulsive therapy and magnetic seizure therapy
2004
-
Antipsychotic treatment effects on progression of brain pathomorphology in first episode schizophrenia
2003
-
Comorbidity and depression treatment.
2003
-
Depression in elderly is associated with blood vessels pathology in lateral orbitofrontal cortex
2003
-
Improved attention is associated with reductions in frontal lobe lactate levels in first episode psychosis
2003
-
Neurocognitive effects of olanzapine and low-dose haloperidol: A two-year treatment study in first episode psychosis
2003
-
Olanzapine induced reductions in frontal lobe lactate levels correlate with treatment response in first episode psychosis
2003
-
Research issues in the study of difficult-to-treat depression.
2003
-
Effects of electroconvulsive shock and magnetic seizure therapy on mossy fiber sprouting and cellular proliferation in the primate hippocampus
2003
-
Neurosteroids and pharmacological treatment strategies in schizophrenia, depression, and anxiety disorders
2002
-
Substance P (NK-1 receptor) antagonists in major depression
2002
-
A pilot proton magnetic resonance spectroscopic imaging study of hippocampus in adult nonhuman primates who underwent stressful rearing conditions as infants
2002
-
Effects of sertraline augmentation of rTMS treatment in major depression on tms motor cortex excitability measures
2002
-
Physiological characteristics of Magnetic Seizure Therapy (MST) induced seizures in nonhuman primates and patients with major depression
2002
-
The predictive value of EEG measures in determining treatment outcomes and cognitive side effects during ECT treatment for major depression
2002
-
Whole brain choline inreased in major depression: An automated proton magnetic resonance spectroscopy study
2001
-
Augmentation of sertraline antidepressant treatment with transcranial magnetic stimulation
2001
-
Flexible treatment strategies in chronic disease: clinical and research implications.
2000
-
185. Magnetic stimulation of the brain: correlates of antidepressant response
2000
-
Cortical excitability in cocaine-dependent subjects; Preliminary data
2000
-
Magnetic stimulation therapy: A novel convulsive technique
1999
-
333. Intracerebral measurement of rTMS and ECS induced voltage in vivo
1998
-
Visuospatial working memory in schizotypal personality disorder
1997
-
Primate models of transcranial magnetic stimulation (TMS) effects
1997
-
Visuospatial working memory in schizotypal personality disorder
1996
-
Prolactin response to ECT: Effects of electrode placement and dosage
1996
-
PERFORMANCE ON TESTS SENSITIVE TO FRONTAL-LOBE DYSFUNCTION AND DEFICIT-LIKE SYMPTOMS IN SCHIZOTYPAL PERSONALITY-DISORDER
1993
-
TASKS FROM MONKEY CORTEX STUDIES AND SPECIFIC PREFRONTAL DYSFUNCTION IN SCHIZOPHRENIA
1993